Global Medical Surgical Artificial Heart Valve Market Growth 2024-2030
The global Medical Surgical Artificial Heart Valve market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Medical Surgical Artificial Heart Valve Industry Forecast” looks at past sales and reviews total world Medical Surgical Artificial Heart Valve sales in 2023, providing a comprehensive analysis by region and market sector of projected Medical Surgical Artificial Heart Valve sales for 2024 through 2030. With Medical Surgical Artificial Heart Valve sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Surgical Artificial Heart Valve industry.
This Insight Report provides a comprehensive analysis of the global Medical Surgical Artificial Heart Valve landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Surgical Artificial Heart Valve portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Surgical Artificial Heart Valve market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Surgical Artificial Heart Valve and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Surgical Artificial Heart Valve.
United States market for Medical Surgical Artificial Heart Valve is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Medical Surgical Artificial Heart Valve is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Medical Surgical Artificial Heart Valve is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Medical Surgical Artificial Heart Valve players cover Edwards Lifesciences, Medtronic, Boston Scientific, Abbott and Corcym, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Surgical Artificial Heart Valve market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Mechanical Valve
Biological Valve
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Edwards Lifesciences
Medtronic
Boston Scientific
Abbott
Corcym
CryoLife
Braile Biomédica
TTK Healthcare
Colibri Heart Valve
JenaValve Technology
Meril Life Sciences
Beijing Balance Medical
CardiMED
Key Questions Addressed in this Report
What is the 10-year outlook for the global Medical Surgical Artificial Heart Valve market?
What factors are driving Medical Surgical Artificial Heart Valve market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Surgical Artificial Heart Valve market opportunities vary by end market size?
How does Medical Surgical Artificial Heart Valve break out type, application?
Please note: The report will take approximately 2 business days to prepare and deliver.